330 related articles for article (PubMed ID: 31933017)
1. Treatment pattern, prognostic factors, and outcome in patients with infection due to pan-drug-resistant gram-negative bacteria.
Kofteridis DP; Andrianaki AM; Maraki S; Mathioudaki A; Plataki M; Alexopoulou C; Ioannou P; Samonis G; Valachis A
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):965-970. PubMed ID: 31933017
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
3. Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients.
Tsioutis C; Kritsotakis EI; Maraki S; Gikas A
Eur J Clin Microbiol Infect Dis; 2010 Mar; 29(3):301-5. PubMed ID: 20063025
[TBL] [Abstract][Full Text] [Related]
4. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
[TBL] [Abstract][Full Text] [Related]
5. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
Huang J; Tang YQ; Sun JY
Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
[TBL] [Abstract][Full Text] [Related]
6. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
Tsioutis C; Kritsotakis EI; Karageorgos SA; Stratakou S; Psarologakis C; Kokkini S; Gikas A
Int J Antimicrob Agents; 2016 Nov; 48(5):492-497. PubMed ID: 27542315
[TBL] [Abstract][Full Text] [Related]
7. The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
Zak-Doron Y; Dishon Benattar Y; Pfeffer I; Daikos GL; Skiada A; Antoniadou A; Durante-Mangoni E; Andini R; Cavezza G; Leibovici L; Yahav D; Eliakim-Raz N; Carmeli Y; Nutman A; Paul M;
Clin Infect Dis; 2018 Nov; 67(12):1815-1823. PubMed ID: 29718143
[TBL] [Abstract][Full Text] [Related]
8. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E;
Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988
[TBL] [Abstract][Full Text] [Related]
11. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.
Chen F; Shen C; Pang X; Zhang Z; Deng Y; Han L; Chen X; Zhang J; Xia Q; Qian Y
Transpl Infect Dis; 2020 Feb; 22(1):e13199. PubMed ID: 31627248
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.
Petrosillo N; Giannella M; Antonelli M; Antonini M; Barsic B; Belancic L; Inkaya A C; De Pascale G; Grilli E; Tumbarello M; Akova M
Antimicrob Agents Chemother; 2014; 58(2):851-8. PubMed ID: 24277037
[TBL] [Abstract][Full Text] [Related]
14. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review.
Nørgaard SM; Jensen CS; Aalestrup J; Vandenbroucke-Grauls CMJE; de Boer MGJ; Pedersen AB
Antimicrob Resist Infect Control; 2019; 8():170. PubMed ID: 31709047
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
Dimitriades K; Morrow BM; Jeena P
Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Qu J; Feng C; Li H; Lv X
Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
[TBL] [Abstract][Full Text] [Related]
17. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study.
Yilmaz GR; Dizbay M; Guven T; Pullukcu H; Tasbakan M; Guzel OT; Tekce YT; Ozden M; Turhan O; Guner R; Cag Y; Bozkurt F; Karadag FY; Kartal ED; Gozel G; Bulut C; Erdinc S; Keske S; Acikgoz ZC; Tasyaran MA
Ann Saudi Med; 2016; 36(3):216-22. PubMed ID: 27236394
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
[TBL] [Abstract][Full Text] [Related]
20. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
